RUSSIA PLANT
August 1st, 2004
BY KEITH NUTHALLTHE EUROPEAN Bank for Reconstruction and Development (EBRD) is planning to lend Euro 15 million to NPO Petrovax Pharm, a Russian niche pharmaceutical company, so it can build a green field plant near Moscow making new generation influenza vaccines for the ex-USSR market. The bank would cover the entire costs of the project, which would see Petrovax collaborating with international player Solvay. Said a memorandum from the EBRD: "It is unique as it combines the achievements of Russian and western scientific research and it promotes local production ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.